Lemtrada adverse events (AEs) may occur more frequently than previously understood, according to an August 2019 medical journal article. This new Lemtrada drug safety information appeared in this article, “Adverse events with fatal outcome associated with alemtuzumab treatment in multiple sclerosis”, published August 12, 2019 by BMC Research … [Read more...]